Table 2 Clinical Outcomes in Patients Who Underwent STVr, STVR and TTVr (2016–2018)
Variable | STVr (n = 92) | STVR (n = 86) | TTVr (n = 84) | P Value |
|---|---|---|---|---|
In-hospital mortality, n (%) | 8 (8.7) | 3 (3.5) | 1 (1.2) | 0.32 |
Length of hospital stay, days | 15.41 ± 15.193 | 24.69 ± 28.807* | 9.57 ± 10.211 | 0.025 |
Total charges, US$ | 379994.53 ± 365008.523* | 470947.27 ± 614177.568* | 198396.71 ± 188943.082 | 0.142 |
Cardiac tamponade, n (%) | 3 (3.3) | 6 (7.0) | 6 (7.1) | 0.297 |
Cardiogenic shock, n (%) | 18 (19.6) | 13 (15.1) | 12 (14.3) | 0.938 |
Cardiac arrest, n (%) | 2 (2.2) | 3 (3.5) | 6 (7.1) | 0.353 |
Third degree atrioventricular block, n (%) | 8 (8.7) | 33 (38.4)* | 1(1.2) | < 0.001 |
Respiratory failure, n (%) | 5 (5.4) | 13 (15.1)* | 1 (1.2) | 0.154 |
Respiratory complications, n (%) | 6 (6.5) | 17 (19.8)* | 1 (1.2) | 0.085 |
Mechanical ventilation use, n (%) | 12 (13) | 23 (26.7) | 6 (7.1) | 0.184 |
IABP, n (%) | 8 (8.7) | 3 (3.5) | 6 (7.1) | 0.972 |
ECMO, n (%) | 4 (4.3) | 1 (1.2) | 2 (2.4) | 0.73 |
Pericardial complications, n (%) | 11 (12) | 17 (19.8) | 12 (14.3) | 0.563 |
Hemopericardium, n (%) | 1 (1.1) | 1 (1.2) | 1 (1.2) | 0.936 |
Bleeding/hematoma post-procedure, n (%) | 5 (5.4) | 10 (11.6) | 6 (7.1) | 0.466 |
Thrombosis due to cardiac prosthetic devices, n (%) | 1 (1.1) | 1 (1.2) | 1 (1.2) | 0.936 |
Acute embolism and thrombosis, n (%) | 2 (2.2) | 1 (1.2) | 6 (7.1) | 0.374 |
Blood transfusion, n (%) | 18 (19.6) | 7 (8.1) | 6 (7.1) | 0.304 |
Acute kidney injury, n (%) | 37 (40.2) | 30 (34.9) | 23 (27.4) | 0.762 |
Fluid and electrolyte disorders, n (%) | 41 (44.6) | 44 (51.2)* | 19 (22.6) | 0.302 |